QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-aug-20-esta-establishment-labs-appointed-fillipo-peter-caldini-to-position-of-president

- SEC Filing

 citigroup-maintains-neutral-on-establishment-labs-hldgs-raises-price-target-to-45

Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Neutral and raises the price target...

 stephens--co-reiterates-overweight-on-establishment-labs-hldgs-maintains-68-price-target

Stephens & Co. analyst George Sellers reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Overweight and maintains ...

 jp-morgan-maintains-overweight-on-establishment-labs-hldgs-lowers-price-target-to-50

JP Morgan analyst Allen Gong maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Overweight and lowers the price target ...

 establishment-labs-hldgs-q2-2024-gaap-eps-062-misses-051-estimate-sales-44117m-beat-43095m-estimate

Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.62) per share which missed the analyst consensus estima...

 establishment-labs-holdings-says-fda-to-begin-pma-preapproval-inspection-of-cos-manufacturing-facility-for-motiva-implants-on-july-22

- SEC Filing

 citigroup-maintains-neutral-on-establishment-labs-hldgs-lowers-price-target-to-50

Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Neutral and lowers the price target...

 mizuho-maintains-buy-on-establishment-labs-hldgs-raises-price-target-to-70

Mizuho analyst Anthony Petrone maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from ...

 the-fdas-center-for-devices-and-radiological-health-has-completed-review-of-establishment-labs-premarket-approval-application-for-motiva-implants-and-says-the-application-is-approvable-subject-to-an-acceptable-fda-inspection-of-manufacturing-facilities

The inspection by the FDA has been rescheduled from the previously confirmed dates to take place within the next thirty days.  

 citigroup-downgrades-establishment-labs-hldgs-to-neutral-maintains-price-target-to-60

Citigroup analyst Joanne Wuensch downgrades Establishment Labs Hldgs (NASDAQ:ESTA) from Buy to Neutral and maintains the pri...

 establishment-labs-hldgs-q1-2024-adj-eps-058-beats-067-estimate-sales-37200m-beat-36001m-estimate

Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate...

 establishment-labs-notes-presentation-of-4-year-results-from-motiva-us-ide-study-at-the-aesthetic-meeting-2024

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health a...

 citigroup-maintains-buy-on-establishment-labs-hldgs-raises-price-target-to-60

Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target fro...

 mizuho-reiterates-buy-on-establishment-labs-hldgs-raises-price-target-to-65

Mizuho analyst Anthony Petrone reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION